PeptiDream Inc. (PPTDF)
5.98
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
PeptiDream EPS Diluted (Quarterly) : -0.0422 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0422 |
| December 31, 2025 | -0.0267 |
| September 30, 2025 | -0.0575 |
| June 30, 2025 | -0.0583 |
| March 31, 2025 | -0.0523 |
| December 31, 2024 | -0.1319 |
| September 30, 2024 | -0.0158 |
| June 30, 2024 | 0.9279 |
| March 31, 2024 | -0.0438 |
| December 31, 2023 | -0.0264 |
| September 30, 2023 | 0.2277 |
| June 30, 2023 | -0.0269 |
| March 31, 2023 | -0.0145 |
| December 31, 2022 | 0.4213 |
| September 30, 2022 | 0.0526 |
| June 30, 2022 | -0.018 |
| March 31, 2022 | -0.0549 |
| December 31, 2021 | 0.0066 |
| September 30, 2021 | 0.1737 |
| June 30, 2021 | 0.015 |
| March 31, 2021 | -0.0164 |
| December 31, 2020 | 0.2762 |
| September 30, 2020 | -0.0142 |
| June 30, 2020 | 0.089 |
| March 31, 2020 | -0.0249 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.0138 |
| June 30, 2019 | 0.1459 |
| March 31, 2019 | 0.006 |
| June 30, 2018 | 0.2265 |
| March 31, 2018 | -0.0224 |
| December 31, 2017 | 0.0085 |
| September 30, 2017 | -0.0497 |
| June 30, 2017 | 0.1082 |
| March 31, 2017 | -0.0143 |
| December 31, 2016 | 0.005 |
| September 30, 2016 | 0.021 |
| June 30, 2016 | 0.0433 |
| March 31, 2016 | 0.0492 |
| December 31, 2015 | 0.0134 |
| September 30, 2015 | 0.0024 |
| June 30, 2015 | 0.0631 |
| March 31, 2015 | -0.0032 |
| December 31, 2014 | 0.0049 |
| September 30, 2014 | -0.0019 |
| June 30, 2014 | 0.0037 |
| March 31, 2014 | -0.002 |
| December 31, 2013 | 0.0094 |
| September 30, 2013 | 0.0007 |
| June 30, 2013 | 0.0003 |
| March 31, 2013 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharma Foods International Co., Ltd. | 0.00 |
| NovelStem International Corp. | -0.0012 |
| Brainstorm Cell Therapeutics, Inc. | -0.1928 |
| Enlivex Ltd. | 25.79 |
| Summit Therapeutics, Inc. | -0.2443 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.449M |
| Revenue (Quarterly) | 30.37M |
| Total Expenses (Quarterly) | 35.82M |
| Enterprise Value | 710.50M |
| Gross Profit Margin (Quarterly) | 42.56% |
| Profit Margin (Quarterly) | -17.94% |
| Earnings Yield | -3.09% |
| Normalized Earnings Yield | -3.089 |